Bellerophon Therapeutics, Inc. of WARREN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-19. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 41 people.
| Name | Role | Location |
|---|---|---|
| Naseem Amin | Director | Warren, NJ |
| Scott Bruder | Director | Warren, NJ |
| Mary Ann Cloyd | Director | Warren, NJ |
| Jens Luehring | Director | Warren, NJ |
| Andre Moura | Director | NEW YORK, NY |
| JONATHAN PEACOCK | Director | LONDON, X0 |
| Daniel Tasse | Director | Chatillon, I0 |
| Adam Weinstein | Director | New York, NY |
| Martin Dekker | Executive Officer | Warren, NJ |
| Amy Edmonds | Executive Officer | Warren, NJ |
| Peter Fernandes | Executive Officer | Warren, NJ |
| Deborah Quinn | Executive Officer | Warren, NJ |
| Megan Schoeps | Executive Officer | Warren, NJ |
| Parag Shah | Executive Officer | Boston, MA |
| Adam B Weinstein | Director | New York, NY |
| David Abrams | Executive Officer | TORONTO, A6 |
| MATTHEW HOLT | Director | Palm Beach, FL |
| Daniel Tasse | Executive Officer | Chatillon, I0 |
| Bryan Roberts | Director | Boulder, CO |
| Robert Nelsen | Director | Seattle, WA |
| Howard Pien | Director | Harrison, NY |
| Andre V Moura | Director | New York, NY |
| JONATHAN PEACOCK | Executive Officer | LONDON, X0 |
| Jens P Luehring | Director | Warren, NJ |
| Mary Ann P Cloyd | Director | Warren, NJ |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2017-10-11 | D | $23.4M | $23.4M |
| 2014-07-02 | D | $1 | $1 |
| 2014-02-21 | D | $1 | $1 |